MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Spinocerebellar ataxia 17: First observation in Russia

    S.A. Klyushnikov, D.A. Prikhodko, N.Y. Abramycheva, M.Y. Krasnov, S.N. Illarioshkin (Moscow, Russia)

    Objective: To report the detection of the first case of spinocerebellar ataxia 17 in Russian population. Background: Autosomal dominant spinocerebellar ataxias (AD SCAs) are clinically…
  • 2016 International Congress

    GAA expansion with clinic/urodynamic findings in Friedreich’s ataxia with LUTS

    P.N.S. Almeida, A.F.A. Musegante, U. Barroso (Salvador, Brazil)

    Objective: This study correlate the number of GAA repetitions of alleles, the duration of the disease, and the age at the onset of the disease…
  • 2016 International Congress

    The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3

    T. Schmidt, A. Sowa, I.M. Martins, M. Abedi, Z. Wang, J. Schmidt, H. Tricoire, O. Riess (Tübingen, Germany)

    Objective: Spinocerebellar ataxia type 3 (SCA3) or Machado-Joseph disease (MJD) is a neurodegenerative disorder caused by a CAG expansion in the MJD1 gene leading to…
  • 2016 International Congress

    Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample

    T. Schmitz-Hübsch, S. Lux, A.U. Brandt, P. Bauer, E. Schlapakow, S. Greschus, H. Gärtner, M.E. Kirlangic, V. Gras, D. Timmann, M. Synofzik, N. Shah, L. Schöls, U. Kopp, T. Oberwahrenbrock, H. Zimmermann, C. Pfueller, E.M. Kadas, M. Rönnefarth, A. Grosch, M. Endres, T. Klockgether, K. Amunts, F. Paul, S. Doss, M. Minnerop (Berlin, Germany)

    Objective: To give a concise description of clinical and imaging features of spinocerebellar ataxia type 14 (SCA14). Background: Since its genetic definition in 2003, the…
  • 2016 International Congress

    Biochemical evaluation in patients with suspected ataxia related to CoQ10 deficiency

    J.L.H. Pedroso, F.G. Ravagnani, M.H. Barros, L.R. Sanches, F.R. Picosse, T.O. Lopes, P.C. Aguiar, M. Chiaratti, C.H. Macabelli, J.H. Arita, M.R. Masruha, O.G. Barsottini, C.C. Ferreiro-Barros (Sao Paulo, Brazil)

    Objective: To investigate CoQ10 levels through skin fibroblasts in patients with suspected ataxia related to CoQ10 deficiency. Background: CoQ10 deficiency may cause complex forms of…
  • 2016 International Congress

    Early clinical features of paraneoplastic cerebellar degeneration: Diagnostic outcomes of adult onset cerebellar ataxia

    J. Zhang, Z. Xu, J.Y.H. Chai, L. Tan (Beijing, People's Republic of China)

    Objective: To investigate whether there are clinical features that would allow us to segregate between paraneoplastic cerebellar degeneration (PCD) from other adult onset cerebellar ataxia.…
  • 2016 International Congress

    Cortical grey matter atrophy in the motor system in Friedreich ataxia: The IMAGE-FRDA study

    I. Harding, L. Selvadurai, L. Corben, M. Stagnitti, E. Storey, G. Egan, M. Delatycki, N. Georgiou-Karistianis (Melbourne, Australia)

    Objective: To examine the anatomical integrity of the motor cortex in Friedreich ataxia (FRDA). Background: FRDA is an inherited neurodegenerative disorder characterised by progressive gait…
  • 2016 International Congress

    Evidence of striatal dopaminergic dysfunction Sydenham’s chorea in remission with (99m)Tc-TRODAT-1 SPECT

    R. Maciel, D. Maia, C.F. de Lima, F. Cardoso (Belo Horizonte, Brazil)

    Objective: To report the findings of reduced striatal dopamine transporter (DAT) density in patients with Sydenham's chorea (SC) in remission assessed by single-photon emission computed…
  • 2016 International Congress

    Juvenile chorea: Diagnostic criterias, prediction of movement disorders

    M.D. Sanoeva, N.A. Mansurova, M. Avezova (Bukhara, Uzbekistan)

    Objective: To determine significant criteria of disease and to predict development of movement disorders depending on severity of disease expression and duration for its promptly…
  • 2016 International Congress

    Phenotypic insights into ADCY5-associated disease

    F.C.F. Chang, A. Westenberger, R.C. Dale, M. Smith, H.S. Pall, B. Perez-Duenas, P. Grattan-Smith, R.A. Ouvrier, N. Mahant, B.C. Hanna, M. Hunter, J.A. Lawson, C. Max, R. Sachdev, E. Meyer, D. Crimmins, D. Pryor, J.G.L. Morris, A. Munchau, D. Grozeva, K.J. Carss, L. Raymond, M.A. Kurian, C. Klein, V.S.C. Fung (Wentworthville, Australia)

    Objective: We provide detailed clinical data on seven patients from six new kindreds with mutations in the ADCY5 gene, in order to expand and define…
  • « Previous Page
  • 1
  • …
  • 1837
  • 1838
  • 1839
  • 1840
  • 1841
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley